Total assets grew 15% year-over-year to $115.3B in 2026Q2, yet equity expanded only 3.8% to $32.7B, with debt-to-equity improving to 0.85 but total debt rising $2.9B, indicating leverage reduction stems from equity growth rather than deleveraging.
Sempra (SRE) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Assets | 115.28B | 110.88B | 96.16B | 87.18B | 78.57B | 72.05B | 66.62B | 65.67B | 60.64B | 50.45B | 47.79B | 41.15B | 39.65B | 37.24B | 36.5B | 33.36B | 30.28B | 28.51B | 26.4B | 30.09B | 28.95B | 29.25B | 23.77B | 22.01B | 17.76B | 15.16B | 15.61B | 11.27B | 10.46B | 10.76B | 4.65B |
| Asset Growth % | 59.4% | 15.31% | 10.29% | 10.95% | 9.06% | 8.14% | 1.46% | 8.29% | 20.18% | 5.58% | 16.13% | 3.78% | 6.46% | 2.04% | 9.42% | 10.15% | 6.21% | 8% | -12.27% | 3.94% | -1.02% | 23.01% | 8.02% | 23.95% | 17.16% | -2.92% | 38.53% | 7.79% | -2.79% | 131.35% | -0.45% |
| PP&E (Net) | 24.19B | 50.27B | 62.61B | 55.68B | 48.44B | 44.49B | 40.55B | 37.04B | 34.44B | 36.5B | 32.93B | 28.04B | 25.9B | 25.46B | 25.19B | 23.57B | 19.88B | 18.28B | 16.86B | 14.88B | 13.18B | 12.1B | 11.09B | 10.47B | 6.83B | 6.22B | 5.73B | 5.39B | 5.44B | 2.94B | 3.07B |
| PP&E / Total Assets % | 20.99% | 45.34% | 65.12% | 63.87% | 61.65% | 61.75% | 60.86% | 56.41% | 56.79% | 72.35% | 68.91% | 68.14% | 65.32% | 68.36% | 69.02% | 70.67% | 65.63% | 64.12% | 63.88% | 49.46% | 45.51% | 41.38% | 46.63% | 47.59% | 38.47% | 41.02% | 36.68% | 47.86% | 52.04% | 27.3% | 66.13% |
| Total Current Assets | 36.29B | 34.84B | 5.29B | 5.47B | 5.91B | 4.38B | 4.51B | 3.34B | 3.65B | 3.34B | 3.11B | 2.89B | 4.18B | 4B | 3.69B | 2.33B | 3.35B | 2.29B | 2.48B | 9.96B | 12.02B | 13.83B | 8.78B | 7.89B | 7.01B | 4.81B | 6.42B | 3.04B | 2.46B | 1.04B | 503.7M |
| Cash & Equivalents | 154M | 2M | 1.56B | 236M | 370M | 559M | 960M | 108M | 102M | 288M | 349M | 403M | 570M | 904M | 475M | 252M | 912M | 7M | 331M | 668M | 924M | 772M | 419M | 432M | 455M | 605M | 637M | 487M | 424M | 624.4M | 173.1M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Inventory | 109M | 561M | 559M | 482M | 403M | 389M | 308M | 277M | 258M | 307M | 258M | 298M | 396M | 287M | 408M | 346M | 258M | 197M | 320M | 224M | 215M | 0 | 172M | 147M | 134M | 289M | 145M | 148M | 151M | 111M | 63.4M |
| Other Current Assets | 34.1B | 32.25B | 423M | 1.64B | 1.38B | 596M | 914M | 933M | 1.62B | 1.01B | 880M | 681M | 1.74B | 1.2B | 1.67B | 379M | 569M | 211M | 286M | 5.18B | 6.79B | 8.33B | 4.45B | 6.09B | 5.53B | 2.97B | 4.41B | 1.7B | 1.14B | 1B | 80.7M |
| Long-Term Investments | 59.27B | 18.89B | 19.07B | 17.65B | 16.82B | 15.81B | 15.21B | 15.1B | 12.96B | 3.56B | 3.12B | 3.97B | 3.98B | 2.61B | 2.45B | 3.17B | 4.32B | 5.61B | 3.83B | 1.98B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 1.6B | 0 | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B | 2.4B | 2.36B | 819M | 931M | 1.02B | 1.11B | 1.04B | 87M | 0 | 73M | 170M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 273M | 0 | 292M | 318M | 344M | 370M | 202M | 213M | 224M | 596M | 548M | 404M | 415M | 426M | 436M | 448M | 453M | 1.67B | 466M | 9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 50.27B | 6.87B | 7.12B | 6.33B | 5.32B | 5.24B | 4.42B | 8.22B | 7.76B | 3.89B | 5.48B | 5.03B | 4.32B | 3.73B | 3.62B | 2.69B | 2.19B | 1.8B | 2.69B | 1.71B | 3.76B | 3.32B | 3.91B | 3.65B | 3.92B | 4.13B | 3.46B | 2.84B | 2.56B | 1.26B | 1.07B |
| Total Liabilities | 71.97B | 68.88B | 58.37B | 53.53B | 49.32B | 44.63B | 41.69B | 43.86B | 41.39B | 35.31B | 32.55B | 28.57B | 27.55B | 25.39B | 25.74B | 22.99B | 20.97B | 19.18B | 18.01B | 21.75B | 21.26B | 22.91B | 18.91B | 18.1B | 17.22B | 12.19B | 12.85B | 7.73B | 7.54B | 7.52B | 2.98B |
| Total Debt | 36.66B | 36.29B | 35.85B | 31.08B | 28.92B | 24.64B | 24.21B | 25.82B | 24.57B | 19.41B | 17.12B | 14.66B | 14.29B | 12.95B | 12.89B | 10.86B | 9.49B | 8.65B | 7.46B | 5.62B | 5.46B | 5.88B | 4.59B | 5.3B | 4.93B | 4.55B | 4.2B | 3.24B | 2.84B | 2.18B | 1.55B |
| Net Debt | 36.51B | 36.28B | 34.28B | 30.84B | 28.55B | 24.09B | 23.25B | 25.71B | 24.47B | 19.12B | 16.77B | 14.26B | 13.72B | 12.04B | 12.42B | 10.61B | 8.57B | 8.54B | 7.13B | 4.96B | 4.53B | 5.11B | 4.17B | 4.87B | 4.48B | 3.95B | 3.57B | 2.75B | 2.41B | 1.55B | 1.38B |
| Long-Term Debt | 31.02B | 27.76B | 31.56B | 27.76B | 24.55B | 21.07B | 21.78B | 20.79B | 20.9B | 16.45B | 14.43B | 13.13B | 12.09B | 11.25B | 11.62B | 10.08B | 8.98B | 7.46B | 6.54B | 4.55B | 4.53B | 4.82B | 4.19B | 3.84B | 4.08B | 3.44B | 3.27B | 2.9B | 2.79B | 3.17B | 1.48B |
| Short-Term Borrowings | 5.64B | 6.13B | 4.29B | 3.32B | 4.37B | 3.58B | 2.42B | 5.03B | 3.75B | 2.97B | 2.69B | 1.53B | 2.2B | 1.69B | 1.27B | 785M | 543M | 1.19B | 951M | 1.07B | 933M | 1.14B | 398M | 1.46B | 851M | 1.12B | 936M | 337M | 43M | 121.7M | 69.9M |
| Capital Lease Obligations | 2.4B | 2.4B | 0 | 0 | 0 | 0 | 0 | 78M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -347M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 22.11B | 21.89B | 9.68B | 10.09B | 9.9B | 10.04B | 6.84B | 9.15B | 7.52B | 6.63B | 5.93B | 4.61B | 5.07B | 4.37B | 4.26B | 4.16B | 3.79B | 3.89B | 3.61B | 10.39B | 10.35B | 12.25B | 9.08B | 8.57B | 7.25B | 5.47B | 7.49B | 3.24B | 2.47B | 2.21B | 507.8M |
| Accounts Payable | 1.42B | 1.46B | 2.24B | 2.21B | 1.99B | 1.67B | 1.36B | 1.23B | 1.16B | 1.35B | 1.35B | 1.13B | 1.2B | 1.09B | 976M | 983M | 755M | 522M | 412M | 3.83B | 1.59B | 1.39B | 1.13B | 788M | 744M | 814M | 1.28B | 546M | 702M | 625M | 175.8M |
| Accrued Expenses | 1.01B | 521M | 0 | 0 | 484M | 479M | 446M | 476M | 440M | 439M | 409M | 423M | 373M | 376M | 337M | 323M | 311M | 264M | 280M | 7.62B | 7.68B | 9.58B | 7.43B | 6.18B | 5.52B | 3.41B | 5.15B | 2.2B | 1.22B | 1.11B | 214.9M |
| Deferred Revenue | 2.85B | 4M | 0 | 0 | 0 | 0 | 0 | -15M | 0 | 150M | 152M | 149M | 144M | 155M | 144M | 142M | 129M | 146M | 155M | 153M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 15.04B | 13.78B | 2.17B | 3.64B | 3B | 4.31B | 2.61B | 2.33B | 2.17B | 1.88B | 1.48B | 1.53B | 1.3B | 1.21B | 1.67B | 1.88B | 1.72B | 1.91B | 1.77B | -2.33B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 330M | 232.3M | 0 |
| Deferred Taxes | 25.15B | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Liabilities | 9.49B | 10.64B | 11.29B | 10.42B | 10.28B | 10.05B | 10.2B | 11.35B | 10.62B | 9.29B | 8.26B | 7.49B | 7.21B | 6.77B | 7.57B | 7.05B | 6.51B | 6.39B | 6.78B | 5.73B | -5B | -5.1B | -4.69B | -4.29B | -4.97B | -4.38B | -4.12B | -3.62B | -3.58B | -4.07B | -2.04B |
| Total Equity | 43.31B | 42B | 37.79B | 33.65B | 29.26B | 27.42B | 24.93B | 21.8B | 19.25B | 15.14B | 15.24B | 12.58B | 12.1B | 11.85B | 10.76B | 10.22B | 9.21B | 9.19B | 8.39B | 8.52B | 7.69B | 6.16B | 4.87B | 3.89B | 3.02B | 2.89B | 3.3B | 3.19B | 3.12B | 1.67B | 1.67B |
| Equity Growth % | 48.17% | 11.14% | 12.28% | 15.03% | 6.7% | 9.97% | 14.35% | 13.28% | 27.13% | -0.66% | 21.16% | 3.96% | 2.11% | 10.11% | 5.29% | 11.03% | 0.22% | 9.51% | -1.53% | 10.77% | 24.84% | 26.62% | 25.06% | 28.59% | 4.6% | -12.42% | 3.51% | 2.34% | 86.21% | 0.04% | 2.11% |
| Shareholders Equity | 32.7B | 31.61B | 31.24B | 28.7B | 27.14B | 26B | 23.39B | 19.95B | 17.16B | 12.69B | 12.97B | 11.83B | 11.35B | 11.03B | 10.38B | 9.84B | 9.21B | 9.19B | 8.15B | 8.52B | 7.69B | 6.16B | 4.87B | 3.89B | 3.02B | 2.89B | 2.9B | 2.99B | 2.91B | 1.67B | 1.67B |
| Minority Interest | 10.6B | 10.38B | 6.55B | 4.96B | 2.12B | 1.42B | 1.54B | 1.86B | 2.09B | 2.45B | 2.27B | 750M | 754M | 822M | 381M | 383M | 0 | 0 | 240M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 404M | 204M | 204M | 0 | 0 |
| Common Stock | 14.76B | 14.7B | 13.52B | 12.2B | 12.16B | 11.86B | 7.05B | 7.48B | 5.54B | 3.15B | 2.98B | 2.62B | 2.48B | 2.41B | 2.22B | 2.1B | 0 | 0 | 0 | 0 | 0 | 2.96B | 2.3B | 2.03B | 1.44B | 1.5B | 1.42B | 1.97B | 1.88B | 1.85B | 291.6M |
| Additional Paid-in Capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.54B | 0 | 0 | 0 | 0 | 0 | 2.22B | 2.1B | 2.04B | 2.42B | 2.27B | 3.2B | 3.25B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 18.07B | 17.09B | 16.98B | 15.73B | 14.2B | 13.55B | 13.67B | 11.13B | 10.1B | 10.15B | 10.72B | 9.99B | 9.34B | 8.83B | 8.44B | 8.22B | 7.33B | 6.97B | 6.24B | 5.46B | 4.68B | 3.59B | 2.96B | 2.3B | 1.86B | 1.48B | 1.16B | 1.1B | 1.07B | 1.16B | 711.6M |
| Accumulated OCI | -144M | -197M | -166M | -150M | -135M | -318M | -500M | -939M | -764M | -626M | -748M | -806M | -497M | -228M | -376M | 0 | -330M | -369M | -513M | -301M | -415M | -386M | -397M | -436M | -472M | -278M | -88M | -81M | -45M | 501.5M | 566.5M |
| Return on Assets (ROA) | 2.04% | 1.77% | 3.12% | 3.71% | 2.84% | 1.9% | 5.95% | 3.48% | 1.89% | 0.52% | 3.08% | 3.34% | 3.02% | 2.73% | 2.48% | 4.29% | 2.55% | 4.11% | 3.94% | 3.8% | 3.66% | 3.44% | 4.06% | 3.26% | 3.59% | 3.37% | 3.19% | 3.63% | 2.77% | 5.61% | 9.16% |
| Return on Equity (ROE) | 5.42% | 4.6% | 8.01% | 9.78% | 7.55% | 5.04% | 16.83% | 10.71% | 6.11% | 1.69% | 9.86% | 10.94% | 9.7% | 8.9% | 8.24% | 14.05% | 8.14% | 12.85% | 13.17% | 13.86% | 15.36% | 16.56% | 21.25% | 18.77% | 19.98% | 16.73% | 13.22% | 12.49% | 12.27% | 25.81% | 25.79% |
| Debt / Equity | 0.85x | 0.86x | 0.95x | 0.92x | 0.99x | 0.90x | 0.97x | 1.18x | 1.28x | 1.28x | 1.12x | 1.17x | 1.18x | 1.09x | 1.20x | 1.06x | 1.03x | 0.94x | 0.89x | 0.66x | 0.71x | 0.96x | 0.94x | 1.36x | 1.63x | 1.57x | 1.27x | 1.02x | 0.91x | 1.30x | 0.93x |
| Debt / Assets | 31.8% | 32.73% | 37.28% | 35.65% | 36.8% | 34.21% | 36.33% | 39.31% | 40.52% | 38.47% | 35.83% | 35.63% | 36.03% | 34.76% | 35.32% | 32.57% | 31.33% | 30.34% | 28.25% | 18.69% | 18.85% | 20.12% | 19.31% | 24.09% | 27.79% | 30.04% | 26.93% | 28.74% | 27.14% | 20.26% | 33.32% |
| Net Debt / EBITDA | 5.93x | 6.24x | 6.51x | 5.82x | 5.15x | 4.91x | 5.28x | 5.96x | 7.53x | 5.06x | 5.59x | 4.27x | 4.69x | 4.09x | 4.78x | 3.87x | 3.45x | 4.02x | 3.70x | 2.24x | 2.02x | 3.03x | 2.20x | 3.13x | 2.83x | 2.51x | 2.43x | 1.68x | 1.55x | 1.92x | 1.77x |
| Book Value per Share | 66.02 | 64.35 | 59.23 | 53.19 | 46.24 | 43.8 | 42.66 | 38.66 | 35.66 | 30 | 30.34 | 25.07 | 24.14 | 23.76 | 21.81 | 21.16 | 18.56 | 18.57 | 16.7 | 16.13 | 14.71 | 12.22 | 10.4 | 18.16 | 14.69 | 14.07 | 7.93 | 13.43 | 6.57 | 7.32 | 7.22 |
Quick answers to the most common questions about buying SRE stock.
As of 2025, Sempra (SRE) had total assets of $110.88B including $34.84B in current assets.
Sempra (SRE) carries total debt of $36.29B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Sempra (SRE) has total shareholders' equity (book value) of $31.61B ($64.35 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Sempra (SRE) reported a current ratio of 1.59x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
LNG execution and financing costs
Metrics are mathematically derived from official filings.
Rate Base Expansion Accelerates Sharply
According to recent quarterly filings, Sempra's total assets grew 15% year-over-year to $115.3B in 2026Q2, driven by a $4.7B quarterly CAPEX surge that signals an accelerating rate base trajectory.
The sequential asset growth from $106.9B in 2025Q3 to $115.3B in 2026Q2 reflects a deliberate push into Texas transmission and LNG infrastructure, with CAPEX nearly doubling quarter-over-quarter. This pace of investment, if sustained, should translate into regulated equity growth, though the lag between spending and rate base recognition means near-term earnings may not fully capture the expansion. The 2026Q2 CAPEX of $4.7B represents a 147% increase from the prior year, suggesting management is front-loading capital into high-return projects.
PPE Composition Signals Strategic Shift
As reported in financial statements, PPE net dropped from $66.0B in 2025Q2 to $24.2B in 2026Q2, a 63% decline that appears tied to reclassification of assets to equity method investments, not asset disposals.
The dramatic PPE reduction coincides with a $15.4B increase in total assets, indicating that Sempra may be consolidating less of its infrastructure assets while retaining economic exposure through equity stakes, particularly in LNG ventures. This accounting shift obscures the true scale of the rate base, as the 80% Oncor stake and LNG projects are now likely captured under equity method accounting rather than as consolidated PPE. Investors should adjust for this reclassification when comparing rate base growth across periods, as the underlying physical assets continue to generate regulated returns.
Leverage Ratios Mask Refinancing Pressure
Based on Sempra's reported figures, debt-to-equity improved from 1.01 in 2025Q2 to 0.85 in 2026Q2, yet total debt rose $2.9B year-over-year, suggesting the ratio improvement stems from equity growth rather than deleveraging.
The equity base expanded from $31.7B to $32.7B over the same period, a modest increase that cannot fully offset the $3.8B rise in total debt, implying the D/E improvement is partly a function of asset reclassification. The current ratio of 1.64 in 2026Q2, up from 0.48 a year earlier, indicates improved short-term liquidity, but this may reflect timing of commercial paper issuance rather than structural strength. With rising interest expenses in the Parent & Other segment, the cost of carrying this debt load warrants close monitoring, especially as the CAPEX program requires continued external financing.
Equity Growth Lags Capital Intensity
According to SEC filings, equity grew only 3.8% year-over-year to $32.7B in 2026Q2, while total assets expanded 15%, indicating that retained earnings and equity issuance are not keeping pace with the capital program.
The equity-to-assets ratio held steady at 0.38, but the absolute gap between asset growth and equity growth suggests increasing reliance on debt and hybrid securities to fund the CAPEX pipeline. ROE of 1.9% in 2026Q2, though depressed by AFUDC timing, implies that the earnings contribution from new rate base is not yet materializing at a level that would organically support the equity base. Dividend coverage remains adequate at 3.8x operating cash flow, but if the CAPEX surge continues, management may need to access ATM equity programs, which could dilute existing shareholders.
Cash Position Signals Revolver Reliance
As reported in quarterly filings, cash dropped to $154M in 2026Q2 from $1.7B in 2025Q1, a 91% decline that suggests Sempra is drawing on credit facilities to fund its $4.7B quarterly CAPEX.
The minimal cash balance, combined with a current ratio of 1.64, indicates that Sempra is operating with a thin liquidity buffer, relying on committed revolvers and commercial paper to bridge timing gaps between capital outlays and regulatory recovery. This is not unusual for a utility in heavy construction mode, but the scale of the LNG and Texas transmission projects means any delay in rate case approvals or project financing could strain liquidity. The $2.0M cash position in 2025Q4 highlights the volatility in cash balances, underscoring the importance of the $8B+ credit facility in maintaining financial flexibility.
Regulatory Recovery Lags CAPEX Surge
Based on Sempra's reported figures, the $4.7B quarterly CAPEX in 2026Q2 exceeds operating cash flow by 150%, implying that regulatory recovery mechanisms have not yet caught up with the accelerated spending.
The gap between capital investment and cash recovery is typical during a rate case cycle, but the magnitude here suggests Sempra is funding growth ahead of regulatory approval, which introduces execution risk if rate cases are delayed or disallowed. The Texas transmission expansion benefits from a more constructive regulatory environment, while California's decoupling mechanisms provide stability but slower recovery timelines. Investors should monitor the timing of the next CPUC and PUCT rate case decisions, as any slippage could pressure the balance sheet and force additional external financing.
PPE Reclassification Obscures Rate Base Risk
The 63% decline in PPE net to $24.2B in 2026Q2, as per financial statements, may indicate that a significant portion of rate base is now held off-balance-sheet, potentially exposing Sempra to valuation risk.
If the reclassification to equity method investments reduces transparency, investors may be underappreciating the leverage embedded in these off-balance-sheet structures, particularly in LNG ventures where cost overruns could crystallize as impairments. The shift also complicates regulatory recovery analysis, as the rate base that regulators authorize may not align with consolidated PPE, creating a mismatch that could affect future returns. This warrants close scrutiny of the equity method investments' carrying values and the terms of any project-level debt, as a downturn in LNG markets could trigger write-downs that the current balance sheet presentation does not fully reveal.